The AU-3S programme is governed by a Steering Group which is comprised of:

• The CEOs of medical products National Regulatory Authorities (NRAs) from countries involved in the programme

• The UK Medicines and Health products Regulatory Authority (MHRA) and the U.S. Food and Drug Administration (FDA) as technical partners

• The WHO, which is represented by both AFRO and EMRO regional offices

• The Bill & Melinda Gates Foundation as the programme funders

• Chair of the AU-3S JSM Group

• AUDA-NEPAD

As the AU-3S programme expands, the overall governance model and members of the Steering Group will be reviewed and adapted as required.

In terms of governance specific to the AU-3S JSM Group, Professor Hannelie Meyer (South Africa) has been elected as the first Chair. As of 01 March 2021, Prof Meyer is the head of The South African Vaccination and Immunisation Centre (SAVIC) at Sefako Makgatho Health Sciences University (SMU). Since joining SAVIC in 2013, Prof Meyer has dedicated her time to immunisation related activities. This includes serving as part of two ministerial advisory committees while also serving in the division of Public Health Pharmacy at SMU. Currently, she is also the Chair of the National Immunisation Safety Expert Committee (NISEC) in South Africa. For further information, click here.

For information about the AU-3S JSM Group – such as the structure of and functions within the Group – please visit the AU-3S JSM Group microsite.